Publications by authors named "Trupti Kolvekar"
Article Synopsis
- - The review discusses how dyslipidaemia contributes to cardiovascular disease (CVD) among HIV-infected patients, highlighting traditional and HIV-related risk factors as well as the impact of antiretroviral therapy (ART) on lipid levels.
- - HIV patients often experience lipid abnormalities due to the virus and older ART drugs, but newer therapies are designed to be more lipid-friendly; consequently, calculating CVD risk in these patients is complex.
- - As life expectancy for HIV patients increases due to advancements in ART, there's a rising incidence of non-HIV-related health issues like CVD, making it essential for all HIV patients to have a CVD risk assessment before starting ART, alongside appropriate interventions for lipid management and other risk factors.
Tuberculosis (TB) remains a serious concern more than two decades on from when the World Health Organization declared it a global health emergency. The alarming rise of antibiotic resistance in Mycobacterium tuberculosis, the etiological agent of TB, has made it exceedingly difficult to control the disease with the existing portfolio of anti-TB chemotherapy. The development of effective drugs with novel mechanism(s) of action is thus of paramount importance to tackle drug resistance.
View Article and Find Full Text PDF